Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Individual-focused guidance to tailor zero based budgeting to personal goals, with simple steps to stay committed and evolving.
19,433 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Cerebras stock is catching attention this week as analysts initiate coverage and AI demand grows. This article breaks...
As SpaceX and other tech contenders loom large in markets, index funds gain ground and 401K savers feel the impact. H...
IonQ stock recently popped in active trading, fueled by rival news and renewed optimism around quantum tech. This gui...
A powerful rally in spacex stock surged again today, led by a game-changing AI acquisition and strong market momentum...
In a bold reprise of his thesis, Michael Saylor argues Bitcoin is the base layer for a new digital capital stack, pus...
Two retirees faced higher Medicare bills two years after cashing out a $60,000 annuity payout, illustrating how timin...
OpenAI's ongoing losses highlight the high-cost path of AI leadership. This article explains why two blue-chip AI sto...
A revealing look at how the crypto world got swept up in an illusion of money and momentum. Learn what happened, why ...
A surprising drop in Sandisk shares has many investors recalibrating their bets on memory chips. This guide explains ...
The AI infrastructure boom has Nvidia leading, but Alphabet's end-to-end AI stack and TPU ecosystem could reshape the...
European regulators press Binance on MiCA licensing as Greece withdraws its application and talks with Ireland and La...